Who owns NEUMORA THERAPEUTICS INC.?
- Ticker: NMRA
- CUSIP Number: 640979100
Tip: Access positions for across all investors
Analyze quarterly positions in Neumora Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Neumora Therapeutics stock
Who bought or sold NEUMORA THERAPEUTICS INC. this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Softbank Group Corp | 7.6M | $130M | 0% | Dec 2023 |
|
FMR | 7.5M | $103M | 33% | Mar 2024 |
|
MIC Capital Management UK | 4.5M | $61M | 0% | Mar 2024 |
|
T. Rowe Price Investment Management | 3.6M | $49M | 100% | Mar 2024 |
|
ICONIQ Capital | 3.4M | $47M | 100% | Mar 2024 |
|
Wellcome Trust Limited, as Trustee of the Wellcome Trust | 3.3M | $46M | 0% | Mar 2024 |
|
Artal Group | 2.9M | $40M | 15% | Mar 2024 |
|
EcoR1 Capital | 2.1M | $29M | 0% | Mar 2024 |
|
Johnson & Johnson | 1.8M | $25M | 103% | Mar 2024 |
|
Citadel Advisors | 1.8M | $25M | -1% | Mar 2024 |
|
Avidity Partners Management | 1.8M | $25M | -10% | Mar 2024 |
|
Hillhouse Capital Advisors | 1.7M | $29M | 0% | Dec 2023 |
|
OrbiMed Advisors | 1.5M | $21M | 0% | Mar 2024 |
|
BlackRock | 986k | $14M | 3842% | Mar 2024 |
|
Soros Capital Management | 904k | $12M | 54% | Mar 2024 |
|
T. Rowe Price Associates | 753k | $10M | 100% | Mar 2024 |
|
Balyasny Asset Management | 688k | $9.5M | 100% | Mar 2024 |
|
Rock Springs Capital Management | 646k | $8.9M | 100% | Mar 2024 |
|
Baker Bros. Advisors | 634k | $8.7M | 100% | Mar 2024 |
|
Geode Capital Management | 452k | $6.2M | 270% | Mar 2024 |
|
Logos Global Management | 382k | $6.2M | 0% | Mar 2024 |
|
Vanguard Group | 334k | $4.6M | -12% | Mar 2024 |
|
Addis & Hill | 315k | $4.2M | 100% | Mar 2024 |
|
Pier Capital | 249k | $3.4M | 100% | Mar 2024 |
|
Schonfeld Strategic Advisors | 249k | $3.4M | -5% | Mar 2024 |
|
Callan Capital | 205k | $2.8M | 100% | Mar 2024 |
|
LMR Partners | 188k | $2.6M | 100% | Mar 2024 |
|
Goldman Sachs Group | 163k | $2.2M | -73% | Mar 2024 |
|
Ensign Peak Advisors | 150k | $2.1M | 0% | Mar 2024 |
|
Kennedy Capital Management | 137k | $1.9M | 100% | Mar 2024 |
|
Millennium Management | 137k | $1.9M | 100% | Mar 2024 |
|
Charles Schwab Investment Management | 125k | $1.7M | -4% | Mar 2024 |
|
Northern Trust | 121k | $1.7M | 100% | Mar 2024 |
|
TD Asset Management | 110k | $1.5M | 100% | Mar 2024 |
|
ALPS Advisors | 106k | $1.8M | 100% | Dec 2023 |
|
Auour Investments | 105k | $1.4M | 100% | Mar 2024 |
|
Hudson Bay Capital Management | 98k | $1.4M | 100% | Mar 2024 |
|
Ieq Capital | 83k | $1.1M | 100% | Mar 2024 |
|
Citigroup | 69k | $941k | 1091% | Mar 2024 |
|
Landscape Capital Management | 66k | $907k | 100% | Mar 2024 |
|
Morgan Stanley | 65k | $899k | 16244% | Mar 2024 |
|
Royal Bank of Canada | 51k | $717k | 927% | Mar 2024 |
|
Bank of New York Mellon | 41k | $564k | -9% | Mar 2024 |
|
Jane Street | 41k | $560k | -54% | Mar 2024 |
|
Wells Fargo & Company | 35k | $481k | 28% | Mar 2024 |
|
Jpmorgan Chase & Co | 35k | $477k | -43% | Mar 2024 |
|
Susquehanna International | 33k | $451k | 14% | Mar 2024 |
|
GSA Capital Partners | 30k | $410k | -36% | Mar 2024 |
|
Wexford Capital | 29k | $401k | 100% | Mar 2024 |
|
Windmill Hill Asset Management | 26k | $359k | 100% | Mar 2024 |
|
UBS Group | 25k | $348k | 9775% | Mar 2024 |
|
Bank of America Corporation | 22k | $304k | 46% | Mar 2024 |
|
Verition Fund Management | 22k | $303k | 100% | Mar 2024 |
|
Nuveen Asset Management | 21k | $285k | 100% | Mar 2024 |
|
Qube Research & Technologies | 18k | $251k | -15% | Mar 2024 |
|
Rhumbline Advisers | 18k | $241k | 12% | Mar 2024 |
|
Wealth Enhancement Advisory Services | 13k | $173k | 100% | Mar 2024 |
|
XTX Topco | 12k | $170k | 100% | Mar 2024 |
|
Barclays | 10k | $143k | -49% | Mar 2024 |
|
Legacy Private Trust | 10k | $138k | 0% | Mar 2024 |
|
Oxford Asset Management | 10k | $138k | 100% | Mar 2024 |
|
MetLife Investment Advisors | 8.5k | $145k | 100% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 8.0k | $110k | 0% | Mar 2024 |
|
American International | 7.4k | $126k | 100% | Dec 2023 |
|
New York State Common Retirement Fund | 7.0k | $96k | 1% | Mar 2024 |
|
Virtus ETF Advisers | 5.9k | $81k | -6% | Mar 2024 |
|
Simplex Trading | 2.8k | $39k | 100% | Mar 2024 |
|
Tower Research Capital | 2.6k | $36k | 100% | Mar 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 2.2k | $30k | -31% | Mar 2024 |
|
Summit Investment Advisors | 1.5k | $21k | 0% | Mar 2024 |
|
California State Teachers Retirement System | 1.5k | $21k | 100% | Mar 2024 |
|
Legal & General Group | 1.4k | $20k | 0% | Mar 2024 |
|
Metropolitan Life Insurance Company | 921.00 | $16k | 100% | Dec 2023 |
|
Amalgamated Bank | 508.00 | $7.0k | -70% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 174.00 | $2.4k | 100% | Mar 2024 |
|
NISA Investment Advisors | 12.00 | $165.000000 | 100% | Mar 2024 |
|
GAMMA Investing | 9.00 | $124.000200 | 100% | Mar 2024 |
|
Covestor | 8.00 | $0 | 100% | Mar 2024 |
|
Pnc Financial Services | 5.00 | $69.000000 | 100% | Mar 2024 |
|
CWM | 3.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Neumora Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Alphabet | Dec 2023 | 405k | $6.9M |
GMT Capital Corp | Dec 2023 | 141k | $2.4M |
Scoggin | Dec 2023 | 125k | $2.1M |
Cormorant Asset Management | Dec 2023 | 92k | $1.6M |
Norges Bank Investment Management | Dec 2023 | 50k | $853k |
Greenland Capital Management | Sep 2023 | 48k | $672k |
First Trust Advisors | Sep 2023 | 27k | $378k |
SG Americas Securities | Dec 2023 | 6.3k | $108k |
Advisory Services Network | Dec 2023 | 200.00 | $3.4k |
Quarry | Dec 2023 | 50.00 | $853.000000 |